Physician

Rashad Mumtaz Khan, M.D.

According to 2025 Medicare claims, Rashad Khan, M.D. (NPI: 1235516725) practices hematology/oncology in the Longview, TX market, with the plurality of this provider's patient population coming from Gregg, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1811944101; TIN: 752131429) and primary practice location at 75601-4756.

Khan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 373 traditional Medicare patients, billed 96,213 HCPCS/CPT codes, and received $1,725,702 in Medicare payments. The top billing code was 80053 (Blood test, comprehensive group of blood chemicals). Part D data shows 628 prescription claims across 121 beneficiaries totaling $942,524 in drug costs, led by Cabometyx (Cabozantinib S-Malate). Open Payments data shows 46 records totaling $2,985. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $2,606 to $942,524. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	129	8,852	$123,361
2022	279	44,220	$612,371
2023	369	87,066	$1,724,157
2024	373	96,213	$1,725,702

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	22	$2,606
2016	22	135	$3,220
2017	22	106	$2,761
2018	20	39	$658
2019	20	30	$85,934
2020	26	49	$73,752
2021	27	46	$7,166
2022	85	283	$382,288
2023	92	481	$553,865
2024	121	628	$942,524

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
80053	Blood test, comprehensive group of blood chemicals	193	677	$10
36415	Insertion of needle into vein for collection of blood sample	194	753	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	186	657	$8
83540	Iron level	178	410	$6
83615	Lactate dehydrogenase (enzyme) level	184	529	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Cabometyx	Cabozantinib S-Malate	11	330	$254,911
Revlimid	Lenalidomide	15	413	$247,716
Erleada	Apalutamide	13	390	$196,997
Abiraterone Acetate	Abiraterone Acetate	15	450	$22,347
Letrozole	Letrozole	55	3,301	$1,058

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	46	$2,985	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Rashad Mumtaz Khan, M.D.?

Tedicare shows public-source Medicare data for Rashad Mumtaz Khan, M.D. (NPI 1235516725), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rashad Mumtaz Khan, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Rashad Mumtaz Khan, M.D.?

Rashad Mumtaz Khan, M.D. is linked to TEXAS ONCOLOGY PA (billing NPI 1811944101) in the available physician profile data.

Does Rashad Mumtaz Khan, M.D. have Open Payments data?

Rashad Mumtaz Khan, M.D. has 46 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.